Compensation award — excluded from discretionary-purchase analysis.
Loading…
Stake as of Dec 31, 2025 · Filed Feb 5, 2026
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
Undefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
20K → 20K shares held
Biogen's Head of Pharm Ops and Tech spent $585 of their very own money to buy Biogen shares.
